Shanghai Haixin Group Co., Ltd. (SHA:600851)

China flag China · Delayed Price · Currency is CNY
8.09
+0.09 (1.12%)
At close: Jan 23, 2026
36.89%
Market Cap6.90B
Revenue (ttm)788.05M
Net Income (ttm)156.25M
Shares Out1.21B
EPS (ttm)0.13
PE Ratio62.52
Forward PEn/a
Dividend0.04 (0.49%)
Ex-Dividend DateJul 29, 2025
Volume41,656,120
Average Volume13,809,767
Open7.99
Previous Close8.00
Day's Range7.92 - 8.28
52-Week Range5.60 - 8.36
Beta0.59
RSI74.41
Earnings DateApr 22, 2026

About Shanghai Haixin Group

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China. [Read more]

Industry Conglomerates
Founded 1986
Employees 715
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600851
Full Company Profile

Financial Performance

In 2024, Shanghai Haixin Group's revenue was 795.88 million, a decrease of -32.70% compared to the previous year's 1.18 billion. Earnings were 150.94 million, a decrease of -9.09%.

Financial Statements